CoreRx & ViroPro Announce Agreement
CoreRx, Inc. and Viropro, Inc. recently announced the two companies have entered into a Reciprocal Referral Agreement. The Agreement will benefit both companies’ existing and potential clients with diverse product pipelines by combining CoreRx’s problem-solving and formulation/processing expertise in small molecules with Viropro’s reputation in the development and manufacturing of biopharmaceutical drugs.
“The agreement is another important step in Viropro’s push to build a global network committed to delivering solutions to advance new medicines. It will also leverage Viropro’s expertise to provide clients with optimized solutions to their biopharmaceutical development challenges,” said Cynthia Tsai, Chairperson and Interim CEO of Viropro, Inc.
“We are pleased we are going to continue to improve upon the technologies we are able to offer our clients,” added Todd R. Daviau, CEO of CoreRx. “Since our inception, CoreRx has been working to meet the challenges of drug delivery and enhance the performance of our clients’ drugs. By addressing the needs of clients in biosimilar and large molecule development, CoreRx will continue to play a role in the development of drug candidates and the diversification of their pipelines.”
Viropro specializes in the development and manufacturing of biopharmaceutical drugs. It offers services to a wide array of pharmaceutical and biotechnology companies, and conducts operations through its subsidiaries, Viropro International Inc. (Montreal, Canada), Biologics Process Development (Poway, CA), and Alpha Biologics (Penang, Malaysia). For more information, visit www.viropro.com.
CoreRx is a contract research organization providing customized preformulation services, formulation development, manufacturing, and analytical services to pharmaceutical, biotechnology, academic, and veterinary clients. The company is renowned for reliably expediting early development activities to speed potential drugs to clinical trials while applying stage-specific scientific knowledge and experience. For more information, visit www.corerxpharma.com.
Total Page Views: 1307
